South and Central America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction

GlobalData’s new report, “South and Central America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery” provides key market data on the South and Central America Diabetes Care Devices market – Argentina, Brazil and Mexico. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Countries covered include Argentina, Brazil and Mexico.
- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the South and Central America Diabetes Care Devices market..
- Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Abbott Laboratories, Novo Nordisk A/S, Bayer HealthCare AG, Becton, Dickinson and Company and others.

Highlights

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the South and Central America Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Report Highlights
F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Abbott Laboratories
Novo Nordisk A/S
Bayer HealthCare AG
Becton, Dickinson and Company
Sanofi
Eli Lilly and Company
Medtronic, Inc.
NIPRO CORPORATION
ARKRAY, Inc.